PT  - JOURNAL ARTICLE
AU  - Thorsten Kahnt
AU  - Susanna C. Weber
AU  - Helene Haker
AU  - Trevor W. Robbins
AU  - Philippe N. Tobler
TI  - Dopamine D2-Receptor Blockade Enhances Decoding of Prefrontal Signals in Humans
AID  - 10.1523/JNEUROSCI.4182-14.2015
DP  - 2015 Mar 04
TA  - The Journal of Neuroscience
PG  - 4104--4111
VI  - 35
IP  - 9
4099  - http://www.jneurosci.org/content/35/9/4104.short
4100  - http://www.jneurosci.org/content/35/9/4104.full
SO  - J. Neurosci.2015 Mar 04; 35
AB  - The prefrontal cortex houses representations critical for ongoing and future behavior expressed in the form of patterns of neural activity. Dopamine has long been suggested to play a key role in the integrity of such representations, with D2-receptor activation rendering them flexible but weak. However, it is currently unknown whether and how D2-receptor activation affects prefrontal representations in humans. In the current study, we use dopamine receptor-specific pharmacology and multivoxel pattern-based functional magnetic resonance imaging to test the hypothesis that blocking D2-receptor activation enhances prefrontal representations. Human subjects performed a simple reward prediction task after double-blind and placebo controlled administration of the D2-receptor antagonist amisulpride. Using a whole-brain searchlight decoding approach we show that D2-receptor blockade enhances decoding of reward signals in the medial orbitofrontal cortex. Examination of activity patterns suggests that amisulpride increases the separation of activity patterns related to reward versus no reward. Moreover, consistent with the cortical distribution of D2 receptors, post hoc analyses showed enhanced decoding of motor signals in motor cortex, but not of visual signals in visual cortex. These results suggest that D2-receptor blockade enhances content-specific representations in frontal cortex, presumably by a dopamine-mediated increase in pattern separation. These findings are in line with a dual-state model of prefrontal dopamine, and provide new insights into the potential mechanism of action of dopaminergic drugs.